Sandy Gibson, DO
Family Medicine · Chicago, ILNPI 1780799387
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $309,273 of the $309,273 with a category attached, or 100.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 99.2% of it on its own, with 2 other manufacturers making up the rest. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $2048.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$307K
- Shire North American Group Inc$2K
- AbbVie$300
What the payments were for
- Consulting fees$309,273100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 148 | $306,698 |
| Shire North American Group Inc | 2 | $2,275 |
| AbbVie | 1 | $300 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$300
How this compares
$309,273 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $628 |
| Cephalexin | 26 | $201 |
| Doxycycline Hyclate | 32 | $198 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $188 |
| Methylprednisolone | 31 | $116 |
| Prednisone | 59 | $96 |
| Azithromycin | 25 | $78 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chicago
- Frank PhillipsChicago$1.6M
- Bradley TorphyChicago$1.3M
- Mandy GittlerChicago$204K
- Igor AltmanChicago$64K
- James DelisChicago$31K
- Tatiana BatistaChicago$26K
- Wen Ho YangChicago$26K
- Abdulmassih AbdulmassihChicago$24K
- Andrew PavlatosChicago$22K
- Quoc DangChicago$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.